Immunogen Inc (DELISTED) (IMGN:DL)
31.23
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 16:00
Immunogen Accounts Receivable (Quarterly): 130.69M for Sept. 30, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 130.69M |
June 30, 2023 | 75.36M |
March 31, 2023 | 27.34M |
December 31, 2022 | 12.60M |
September 30, 2022 | 0.042M |
June 30, 2022 | 0.909M |
March 31, 2022 | 1.19M |
December 31, 2021 | 4.467M |
September 30, 2021 | 0.221M |
June 30, 2021 | 0.007M |
March 31, 2021 | 0.093M |
December 31, 2020 | 0.035M |
September 30, 2020 | 5.05M |
June 30, 2020 | 0.313M |
March 31, 2020 | 0.054M |
December 31, 2019 | 7.50M |
September 30, 2019 | 0.094M |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.233M |
December 31, 2018 | 1.701M |
September 30, 2018 | 2.115M |
June 30, 2018 | 0.019M |
March 31, 2018 | 0.034M |
December 31, 2017 | 2.649M |
September 30, 2017 | 2.521M |
Date | Value |
---|---|
June 30, 2017 | 1.024M |
March 31, 2017 | 3.893M |
September 30, 2016 | 0.316M |
June 30, 2016 | 0.883M |
March 31, 2016 | 0.104M |
December 31, 2015 | 0.803M |
September 30, 2015 | 6.812M |
June 30, 2015 | 5.088M |
March 31, 2015 | 0.754M |
December 31, 2014 | 3.109M |
September 30, 2014 | 1.838M |
June 30, 2014 | 1.896M |
March 31, 2014 | 0.036M |
December 31, 2013 | 3.818M |
September 30, 2013 | 5.789M |
June 30, 2013 | 0.00 |
March 31, 2013 | 5.446M |
December 31, 2012 | 1.286M |
September 30, 2012 | 0.853M |
June 30, 2012 | 0.129M |
March 31, 2012 | 1.43M |
December 31, 2011 | 21.21M |
September 30, 2011 | 0.001M |
June 30, 2011 | 4.668M |
March 31, 2011 | 2.271M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
130.69M
Maximum
Sep 2023
14.78M
Average
0.611M
Median
Accounts Receivable (Quarterly) Benchmarks
AbbVie Inc | 11.95B |
Pfizer Inc | 10.99B |
Johnson & Johnson | 14.95B |
Merck & Co Inc | 11.37B |
Cerevel Therapeutics Holdings Inc | -- |